Sanofi: Sanofi launches new cholesterol-lowering injection in Korea with health insurance coverage
Sanofi Korea announced the launch of Praluent Pen 300mg (ingredient: alirocumab) on Tuesday, following its inclusion in the national health insurance reimbursement list. The new formulation is designed to provide a more convenient and effective treatment option for patients with high cholesterol and
Read full article »
Sanofi is a France-based healthcare firm that develops and markets pharmaceutical drugs and OTC medicines for the treatment of a range of diseases such as diabetes and cancer.
Read more